Newsroom Navigation

Contact Info:
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112

public.affairs@hci.utah.edu

801-587-7639

View archived press releases

Press Releases

HCI Scientist Receives $1M Award to Fund Cancer Research
News, Press Releases

HCI Scientist Receives $1M Award to Fund Cancer Research

SALT LAKE CITY—Jody Rosenblatt, Ph.D., a cell biologist at Huntsman Cancer Institute and an associate professor of oncological sciences at the University of Utah has been selected as a Howard Hughes Medical Institute (HHMI) Faculty Scholar, HHMI announced today: https://www.hhmi.org/news/philanthropies-announce-selection-faculty-scholars. The award provides $1 million to fund her research over the course of five years.

Read More

Improving Cancer Prevention and Care among Underserved Individuals Focus of New Huntsman Center for HOPE
News, Press Releases

Improving Cancer Prevention and Care among Underserved Individuals Focus of New Huntsman Center for HOPE

SALT LAKE CITY—Officials at Huntsman Cancer Institute (HCI) at the University of Utah today announced the creation of a new center to be housed in the soon-to-be-completed expansion of HCI’s research enterprise, the Primary Children’s and Families’ Cancer Research Center. The new center will be called the Huntsman Center for Health Outcomes and Population Equity (HOPE) and will focus on discovering new ways to prevent and treat cancer among underserved populations, including individuals living in poverty and residents of rural (between 6.1 and 99.9 persons/sq. mile) and frontier (<6.1 persons/sq. mile) areas.

Read More

New Huntsman Cancer Institute Program Personalizes Lifelong Patient Care
News, Press Releases

New Huntsman Cancer Institute Program Personalizes Lifelong Patient Care

Huntsman Cancer Institute (HCI) at the University of Utah is launching a unique program, called HCI-Total Cancer Care, which will follow patients through cancer screenings, treatments, and into good health throughout their lives. The program, which is borne out of HCI’s membership in the Oncology Research Information Exchange Network (ORIEN), utilizes patient data to help match patients to clinical trials and treatment developments happening across the country, offering never-before-seen access to cutting edge innovations in cancer care, while tracking a patient’s health throughout his or her lifetime.

Read More

beckerle

Dalai Lama Meets with Huntsman Cancer Institute Leaders, Blesses Patients
News, Press Releases

Dalai Lama Meets with Huntsman Cancer Institute Leaders, Blesses Patients

His Holiness the 14th Dalai Lama of Tibet met with patients and leaders of Huntsman Cancer Institute (HCI) and the University of Utah during a brief visit to Huntsman Cancer Institute today, Tuesday, June 21. His visit coincides with his appearance later in the afternoon at the University’s Jon M. Huntsman Center where he will speak about compassion and universal responsibility.

Read More

Study Contradicts Belief that Cancer Protects against Alzheimer’s
News, Press Releases

Study Contradicts Belief that Cancer Protects against Alzheimer’s

Despite studies that claim people with cancer are less likely to develop Alzheimer’s disease—raising the possibility that what triggers cancer also prevents the neurodegenerative disorder—a new investigation finds a more somber explanation. Many cancer patients don’t live long enough to get Alzheimer’s. The research, led by investigators at Huntsman Cancer Institute at the University of Utah, was published in The Journals of Gerontology: Series B.

Read More

Huntsman Cancer Institute CEO to Join Federal Moonshot Blue Ribbon Panel
News, Press Releases

Huntsman Cancer Institute CEO to Join Federal Moonshot Blue Ribbon Panel

Huntsman Cancer Institute’s CEO and director, Mary Beckerle, PhD, has been asked to join Vice President Joe Biden’s Moonshot Program Initiative as an invited member of a new Blue Ribbon Panel, tasked with advising the National Cancer Advisory Board (NCAB) on the scientific opportunities available to accelerate progress against cancer and evaluate potential new investments in cancer research.

Read More

beckerle

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patients
News, Press Releases

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patients

Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA), has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.

Read More

colon cancer, cancer prevention, cancer genetics

Huntsman Cancer Institute Hosts Vice President Joe Biden
News, Press Releases

Huntsman Cancer Institute Hosts Vice President Joe Biden

(February 26, 2016) – Today Huntsman Cancer Institute (HCI) hosted Vice President Joe Biden as a part of the White House administration’s “moonshot” initiative to double the rate of progress toward curing cancer. During his visit, the vice president toured the facility, was given an inside look at the Utah Population Database and participated in a roundtable discussion comprised of Huntsman Cancer Foundation board chairman Jon Huntsman Jr., CEO and director of HCI Dr. Mary Beckerle and Senator Orrin Hatch. Local cancer survivors and physicians, researchers and experts in the field also participated in the roundtable.

Read More

beckerle

When Cancer of Unknown Origin Strikes, Family Members Are At Increased Risk
News, Press Releases

When Cancer of Unknown Origin Strikes, Family Members Are At Increased Risk

Cancer usually begins in one location and then spreads, but in 3-5% of cancer patients, the tissue where a cancer began is unknown. In these individuals a cancer diagnosis is made because it has metastasized to other sites. Patients with these so-called “cancers of unknown primary,” or CUP, have a very poor prognosis, with a median survival of three months. A new study in the Journal of the American Medical Association (JAMA) Oncology finds that family members of CUP patients are at higher risk of developing CUP themselves, as well as cancers of the lung, pancreas, colon, and some cancers of the blood.

Read More

cancer, genetics

Possible New Mechanism for Aspirin’s Role in Cancer Prevention
News, Press Releases

Possible New Mechanism for Aspirin’s Role in Cancer Prevention

Aspirin has been shown to decrease the risk of colorectal cancer and possibly other cancers. However, the risk of side effects, including in some cases severe gastrointestinal bleeding, makes it necessary to better understand the mechanisms by which aspirin acts at low doses before recommending it more generally as a preventative, says Cornelia Ulrich, PhD, Senior Director of Population Sciences at Huntsman Cancer Institute in Salt Lake City.

Read More

A Cancer-Killing Cold Sore Virus Fights Late Stage Melanoma
News, Press Releases

A Cancer-Killing Cold Sore Virus Fights Late Stage Melanoma

The U.S. Food and Drug Administration announced October 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the U.S. The drug was approved for use against late stage melanoma, a deadly skin cancer that can be difficult to treat.

Read More

Why Elephants Rarely Get Cancer
News, Press Releases

Why Elephants Rarely Get Cancer

Why elephants rarely get cancer is a mystery that has stumped scientists for decades. A study led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah and Arizona State University, and including researchers from the Ringling Bros. Center for Elephant Conservation, may have found the answer.

Read More

Study Finds Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults
News, Press Releases

Study Finds Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults

Children with cancer have a good chance of surviving the disease—today more than 80% survive due to advances in treatment and care. However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.

Read More

Characterization of the Nutrient Needs of Triple Negative Breast Cancer Leads to the Identification of a Molecular Signature for Cancer Outcomes
News, Press Releases

Characterization of the Nutrient Needs of Triple Negative Breast Cancer Leads to the Identification of a Molecular Signature for Cancer Outcomes

Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. In a new study published in the journal Proceedings of the National Academy of Sciences (PNAS), researchers at Huntsman Cancer Institute and the University of Utah have identified a molecular mechanism that triple negative breast cancer cells use to survive and grow.

Read More

Noted UCSF Scientist Joins Research Team at Huntsman Cancer Institute
News, Press Releases

Noted UCSF Scientist Joins Research Team at Huntsman Cancer Institute

Martin McMahon, Ph.D., joins Huntsman Cancer Institute (HCI) at the University of Utah in August as Professor in the Department of Dermatology and HCI Senior Director of Pre-Clinical Translation. Professor McMahon is currently the Efim Guzik Distinguished Professor of Cancer Biology at the University of California, San Francisco and Assistant Director of Professional Education and Co-leader of the Helen Diller Family Comprehensive Cancer Center (HCFCCC) Developmental Therapeutics Program.

Read More

Cell Mechanism Discovered That May Cause Pancreatic Cancer
News, Press Releases

Cell Mechanism Discovered That May Cause Pancreatic Cancer

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have found that defects in how cells are squeezed out of overcrowded tissue to die, a process called extrusion, may be a mechanism by which pancreatic cancer begins. From these findings, they may have identified an effective way to reverse the defective extrusion’s effects without destroying normal tissues nearby. The results were published in the latest edition of the journal eLife.

Read More

New Study Findings Help Physicians and Patients Determine Prostate Cancer Risk
News, Press Releases

New Study Findings Help Physicians and Patients Determine Prostate Cancer Risk

A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man’s uncles and great-grandparents, among other second- and third-degree relatives, had prostate cancer could be as important as looking at whether his father had prostate cancer. A more complete family history would give physicians a new tool to decide whether or not a PSA test was appropriate.

Read More


Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.

Tonya Papanikolas
Public Affairs Manager
Phone: 801-587-7639
tonya.papanikolas@hci.utah.edu

Amie Parker
Public Relations Associate
Phone: 801-213-5755
amie.parker@hci.utah.edu

Jill Woods
Administrative Assistant
Phone: 801-585-5321
Fax: 801-585-0900
jill.woods@hci.utah.edu

After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.